Publication: Infection in systemic lupus erythematosus.
2
item.page.dc.date.issued
1993-10-01
item.page.dc.type
item.page.dc.identifier.issn
01252208
item.page.dc.identifier.other
2-s2.0-0027676818
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Journal of the Medical Association of Thailand. Vol.76, No.10 (1993), 542-548
punsarn.item.page.citation
S. Janwityanuchit, K. Totemchokchyakarn, K. Krachangwongchai, M. Vatanasuk Infection in systemic lupus erythematosus.. Journal of the Medical Association of Thailand. Vol.76, No.10 (1993), 542-548. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/22667
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Infection in systemic lupus erythematosus.
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
A review of 1,069 total admissions of 537 systemic lupus erythematosus (SLE) patients during a 10-yr period at Ramathibodi Hospital showed that 220 episodes which occurred in 137 patients (25.5%) were motivated by infection. Skin was the most common site (23%) with Herpes zoster being the most common organism (15.5%) found in our lupus patients. However, if we considered only major infections, pulmonary tuberculosis, salmonella septicemia and urinary tract infection by E. coli would be the most frequent complications respectively. In the absence of immunosuppressive therapy, infections coincided with the initial manifestation of SLE in 25 patients and were associated with exacerbation of the disease in 20 patients. Mean SLEDAI score in these patients was 8.8, suggesting that active lupus link together with infection. Steroid therapy influenced the rate of opportunistic infections (p = 0.006). Infections were determined to be the cause of death in 23 of 77 patients (29.9%). Opportunistic pathogens played an equal role as other common bacterial organisms in these fatal cases. SLE patients who died from infections were treated with cyclophosphamide in higher proportion than those with no infectious complication (p = 0.025). Our study demonstrated the rate, nature and predisposing factors of infection in SLE which may lead to better anticipation and diminution of morbidity and mortality related to infection in hospitalized patients with SLE.